UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034938
Receipt number R000039829
Scientific Title Follow-up study of endoscopic necrosectomy for severe acute pancreatitis
Date of disclosure of the study information 2018/11/19
Last modified on 2019/11/25 18:13:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Follow-up study of endoscopic necrosectomy for severe acute pancreatitis

Acronym

FSEN

Scientific Title

Follow-up study of endoscopic necrosectomy for severe acute pancreatitis

Scientific Title:Acronym

FSEN

Region

Japan


Condition

Condition

acute pancreatitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To declare the efficacy and safety of endoscopic necrosectomy for patients with necrotizing pancreatitis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of serious complications or death within 6 months of the onset of acute pancreatitis.

Key secondary outcomes

Internal and external secretion failure, bile duct narrowing, treatment times of drainage and necroseectomy, hospital stay and ICU staying period, cost


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Place the tube under the endoscopic ultrasound and drainage the pancreatic necrosis site. If improvement can not be obtained by drainage alone, endoscopic necrosectomy is performed. The necrosectomy is repeated up to 8 times at a frequency of once to twice a week.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

a patient with Infectious pancreatic necrosis
A state in which endoscopic treatment is possible

Key exclusion criteria

(1) Cases with bleeding tendency
(2) Case in which insertion of endoscope is difficult
(3) Case in which pancreatic necrosis part can not be visualized by ultrasonic endoscope (EUS)
(4) Patients requiring emergency surgical treatment (gastrointestinal perforation, intestinal necrosis, bleeding which does not respond to medical treatment)
(5) During pregnancy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Masamune

Organization

Tohoku University

Division name

Division of gastroenterology

Zip code

022-717-7171

Address

Sendai city, Aoba-ku, Seiryo-machi 1-1

TEL

022-717-7171

Email

amasamune@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Kiyoshi
Middle name
Last name Kume

Organization

Tohoku University

Division name

Division of gastroenterology

Zip code

022-717-7171

Address

Sendai city, Aoba-ku, Seiryo-machi 1-1

TEL

022-717-7171

Homepage URL


Email

kkume@med.tohoku.ac.jp


Sponsor or person

Institute

Division of gastroenterology, Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Division of gastroenterology, Tohoku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University

Address

Sendai city, Aoba-ku, Seiryo-machi 1-1

Tel

022-728-4105

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 12 Month 18 Day

Date of IRB

2018 Year 12 Month 12 Day

Anticipated trial start date

2018 Year 12 Month 25 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 19 Day

Last modified on

2019 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039829


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name